LabConcept ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.3% 1.3% 1.3% 1.3% 1.3%  
Bankruptcy risk  3.2% 7.4% 2.0% 4.4% 3.5%  
Credit score (0-100)  57 33 68 47 52  
Credit rating  BBB BB A BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.4 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  938 1,370 3,626 1,308 1,259  
EBITDA  195 110 1,334 -446 144  
EBIT  185 83.0 1,307 -490 71.9  
Pre-tax profit (PTP)  174.6 20.5 1,294.0 -516.4 30.5  
Net earnings  136.2 15.6 1,008.6 -385.8 22.9  
Pre-tax profit without non-rec. items  175 20.5 1,294 -516 30.5  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  439 455 1,463 1,078 1,101  
Interest-bearing liabilities  439 781 910 1,203 1,264  
Balance sheet total (assets)  1,809 2,893 3,627 3,389 2,958  

Net Debt  439 731 581 874 1,140  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  938 1,370 3,626 1,308 1,259  
Gross profit growth  -5.1% 46.1% 164.6% -63.9% -3.7%  
Employees  3 4 6 4 3  
Employee growth %  0.0% 33.3% 50.0% -33.3% -25.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,809 2,893 3,627 3,389 2,958  
Balance sheet change%  -12.6% 59.9% 25.4% -6.6% -12.7%  
Added value  194.5 109.9 1,333.6 -463.3 143.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  10 7 -54 176 -144  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 -1.0 1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  19.7% 6.1% 36.0% -37.5% 5.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  9.5% 3.5% 40.1% -14.0% 2.3%  
ROI %  27.6% 7.2% 64.1% -18.6% 2.9%  
ROE %  36.7% 3.5% 105.2% -30.4% 2.1%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  47.5% 40.8% 60.4% 53.1% 61.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  225.8% 665.5% 43.5% -196.2% 792.0%  
Gearing %  100.0% 171.7% 62.2% 111.6% 114.9%  
Net interest  0 0 0 0 0  
Financing costs %  4.8% 10.2% 1.5% 2.5% 3.4%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.5 1.5 2.6 1.7 2.2  
Current Ratio  1.9 1.7 3.2 2.2 2.8  
Cash and cash equivalent  0.0 49.7 329.0 328.5 124.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  794.0 1,081.2 2,393.1 1,652.6 1,693.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  65 27 222 -116 48  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  65 27 222 -111 48  
EBIT / employee  62 21 218 -123 24  
Net earnings / employee  45 4 168 -96 8